XML 122 R108.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment Reporting - Reconciliation of Adjusted EBITDA (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
General and administrative expenses $ (197.3) $ (155.5) $ (247.0)
Depreciation and amortization (256.6) (243.0) (218.7)
Government, class action, and related settlements 0.0 (2.8) 0.0
Loss on early extinguishment of debt (1.0) (2.3) (7.7)
Net income attributable to noncontrolling interests (105.0) (84.6) (87.1)
Gain on consolidation of joint venture formerly accounted for under the equity method of accounting 0.0 0.0 19.2
Income from continuing operations before income tax expense 657.2 472.6 562.3
Inpatient Rehabilitation Hospital and Home Health and Hospice      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Total Segment Adjusted EBITDA 1,168.3 986.3 1,095.4
Segment Reconciling Items      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
General and administrative expenses (197.3) (155.5) (247.0)
Depreciation and amortization (256.6) (243.0) (218.7)
Loss on disposal or impairment of assets (0.4) (11.6) (11.1)
Government, class action, and related settlements 0.0 (2.8) 0.0
Loss on early extinguishment of debt (1.0) (2.3) (7.7)
Interest expense and amortization of debt discounts and fees (164.6) (184.2) (159.7)
Net income attributable to noncontrolling interests 105.0 84.6 87.1
SARs mark-to-market impact on noncontrolling interests 0.0 0.0 5.0
Change in fair market value of equity securities 0.6 0.4 0.8
Gain on consolidation of joint venture formerly accounted for under the equity method of accounting 3.2 2.2 19.2
Payroll taxes on SARs exercise $ 0.0 $ (1.5) $ (1.0)